HBM Genomics is a venture capital firm investing in early-stage and later-stage U.S. life sciences companies, with a focus on genomics-enabled healthcare, life science tools, clinical diagnostics, therapeutics, food safety testing and oncology-related technologies. The firm backs entrepreneurs building science and technology businesses addressing unmet needs, with portfolio exposure including Clear Labs, Genalyte, Insitro, Seer, Gencove and Cellanome.